Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive versus standard renin-angiotensin and statin therapy for idiopathic chronic glomerulonephritis
ACTRN12610000034033Phase 4Completed
- Sponsor
- Azienda USL Toscana Nord Ovest
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ramipril, irbesartan, spironolactone and atorvastatin, sponsored by Azienda USL Toscana Nord Ovest. Started Jan 2003; status: completed.
02
Drugs
ramiprilirbesartanspironolactoneatorvastatin
Beyond the preview
Go deeper on ACTRN12610000034033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000034033.